Overview

HYZAAR vs. Ramipril for Diabetes (0954A-245)(COMPLETED)

Status:
Completed
Trial end date:
2002-10-16
Target enrollment:
Participant gender:
Summary
A study to test the safety and efficacy of HYZAAR as compared to Ramipril in patients with type 2 diabetes mellitus (high blood sugar) and hypertension (high blood pressure).
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Hydrochlorothiazide
Losartan
Ramipril